サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1672034

臨床試験キットの世界市場：産業分析・規模・シェア・成長・動向・予測 (2025-2032年)

Clinical Trial Kits Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
臨床試験キットの世界市場：産業分析・規模・シェア・成長・動向・予測 (2025-2032年)
出版日: 2025年02月26日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な洞察

  • 臨床試験キットの市場規模 (2025年)：21億米ドル
  • 市場規模の予測 (2032年)：47億米ドル
  • 世界の市場成長率 (2025～2032年)：CAGR 12.5%

市場促進要因：

世界の臨床試験キットの市場は、多様な患者集団からの効率的なデータ収集を可能にする分散型臨床試験 (DCT) の採用拡大など、いくつかの重要な要因によって推進されています。慢性疾患の増加や、医薬品研究への投資の増加も市場拡大の原動力となっています。また、サンプル出荷のリアルタイム追跡やデータ収集の自動化など、デジタルヘルスソリューションの進歩が臨床試験の信頼性と有効性を高めています。より迅速な医薬品承認への需要と費用対効果の高い試験手法へのニーズも市場拡大に寄与しています。

市場機会：

臨床試験キットの市場は、技術の進歩、研究イニシアチブの拡大、臨床試験におけるAIの統合の増加により、大きな成長機会が示されています。個別化医療とバイオマーカーに基づく研究に対する需要の高まりも特殊な臨床試験キットに新たな道を開いています。さらに、製薬企業とCROの戦略的提携により、在宅試験やハイブリッド試験など、試験手法の革新が促進されています。また、環境に優しく持続可能な臨床試験キットの開発は、世界の持続可能性目標を達成する上で競合上の優位性をもたらします。

当レポートでは、世界の臨床試験キットの市場を調査し、市場の定義と概要、市場促進要因・抑制要因、各種動向、市場機会、課題、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲・定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

  • サービス採用分析
  • 規制状況
  • バリューチェーン分析
  • 主要な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第5章 世界の臨床試験キット市場の展望

  • 主なハイライト
  • 市場規模の分析・予測
  • 世界の臨床試験キット市場の展望：サービスタイプ別
  • 世界の臨床試験キット市場の展望：フェーズ別
    • イントロダクション/主な調査結果
    • 過去の市場規模の分析
    • 現在の市場規模の分析・予測
    • 市場の魅力分析

第5章 世界の臨床試験キット市場の展望：地域別

  • 主なハイライト
  • 過去の市場規模の分析：地域別
  • 現在の市場規模の分析・予測：地域別
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第6章 北米の臨床試験キット市場の展望

第7章 欧州の臨床試験キット市場の展望

第8章 東アジアの臨床試験キット市場の展望

第9章 南アジア・オセアニアの臨床試験キット市場の展望

第10章 ラテンアメリカの臨床試験キット市場の展望

第11章 中東・アフリカの臨床試験キット市場の展望

第12章 競合情勢

  • 市場シェア分析
  • 市場構造
  • 企業プロファイル (詳細- 概要、財務、戦略、最近の動向)
    • Azenta Life Sciences
    • Q2 Solutions
    • Patheon
    • LabCorp drug development
    • Charles River Laboratories
    • LabConnect
    • Almac group
    • Precision medicine group
    • Cerba research
    • Alpha Laboratories Ltd
    • Marken SAS
    • Clinigen

第13章 付録

目次
Product Code: PMRREP33246

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial kits. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial kits market from 2025 to 2032.

Key Insights:

  • Clinical Trial Kits Market Size (2025E): US$ 2.1 Bn
  • Projected Market Value (2032F):US$ 4.7 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032):12.5%

Clinical Trial Kits Market - Report Scope:

Clinical trial kits play a crucial role in streamlining the process of conducting clinical research by providing pre-packaged materials for sample collection, testing, and data documentation. These kits are essential in decentralized and remote trials, ensuring efficiency, accuracy, and compliance with regulatory standards. The market serves pharmaceutical and biotechnology companies, contract research organizations (CROs), academic institutions, and healthcare providers. Market growth is driven by increasing clinical trials for drug development, the rise in personalized medicine, and technological advancements in remote sample collection.

Market Growth Drivers:

The global clinical trial kits market is propelled by several key factors, including the growing adoption of decentralized clinical trials (DCTs), enabling efficient data collection from diverse patient populations. The rise in chronic diseases, coupled with increasing investments in drug research, fuels market expansion. Additionally, advancements in digital health solutions, including real-time tracking of sample shipments and automated data collection, enhance the reliability and effectiveness of clinical trials. The demand for faster drug approvals and the need for cost-effective trial methodologies further contribute to market growth.

Market Restraints:

Despite its promising growth, the clinical trial kits market faces challenges related to regulatory compliance, logistical complexities, and high operational costs. Stringent regulatory requirements governing clinical trials and the transportation of biological samples increase compliance burdens. Moreover, logistical challenges associated with sample integrity, transportation delays, and storage conditions hinder market efficiency. The high cost of customized trial kits, particularly for rare diseases and niche applications, limits widespread adoption in cost-sensitive markets.

Market Opportunities:

The clinical trial kits market presents significant growth opportunities driven by technological advancements, expanding research initiatives, and the increasing integration of artificial intelligence in clinical trials. The rising demand for personalized medicine and biomarker-based studies creates new avenues for specialized trial kits. Additionally, strategic collaborations between pharmaceutical companies and CROs facilitate innovation in trial methodologies, including home-based and hybrid trials. The development of eco-friendly and sustainable trial kits also offers a competitive advantage in meeting global sustainability goals.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the clinical trial kits market globally?
  • How are decentralized clinical trials influencing market dynamics?
  • What role do technological advancements play in improving trial efficiency?
  • Who are the key players shaping the market, and what strategies are they adopting?
  • What are the emerging trends and future prospects in the global clinical trial kits market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial kits market, including Thermo Fisher Scientific, Labcorp Drug Development, Almac Group, and Marken, focus on innovation, strategic partnerships, and expansion into emerging markets. These companies invest in automation, AI-driven logistics, and temperature-controlled packaging solutions to enhance sample integrity and trial efficiency. Collaborations with pharmaceutical firms, regulatory bodies, and technology providers facilitate seamless clinical trial execution and market penetration. Additionally, the development of flexible and patient-centric trial kits supports the industry's shift toward decentralized and virtual clinical trials.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Labcorp Drug Development
  • Almac Group
  • Marken
  • PPD Inc.
  • Medpace Holdings, Inc.
  • Catalent Pharma Solutions
  • Parexel International Corporation
  • Q2 Solutions
  • ICON plc

Key Segments Covered in Clinical Trial Kits Industry Survey

By Service Type:

  • Kitting Solutions
  • Logistics

By Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Clinical Trial Kits Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Service Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Clinical Trial Kits Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn ) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
  • 4.3. Global Clinical Trial Kits Market Outlook: Service Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn ) Analysis, By Service Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
      • 4.3.3.1. Kitting Solutions
        • 4.3.3.1.1. Drugs Kits
        • 4.3.3.1.2. Sample Collection Kits
      • 4.3.3.2. Logistics
        • 4.3.3.2.1. Transportation
        • 4.3.3.2.2. Warehousing & Storage
        • 4.3.3.2.3. Other Logistics
    • 4.3.4. Market Attractiveness Analysis: Service Type
  • 4.4. Global Clinical Trial Kits Market Outlook: Phase
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn ) Analysis, By Phase, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
      • 4.4.3.1. Phase I
      • 4.4.3.2. Phase II
      • 4.4.3.3. Phase III
      • 4.4.3.4. Phase IV
    • 4.4.4. Market Attractiveness Analysis: Phase

5. Global Clinical Trial Kits Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Clinical Trial Kits Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Service Type
    • 6.2.3. By Phase
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 6.4.1. Kitting Solutions
      • 6.4.1.1. Drugs Kits
      • 6.4.1.2. Sample Collection Kits
    • 6.4.2. Logistics
      • 6.4.2.1. Transportation
      • 6.4.2.2. Warehousing & Storage
      • 6.4.2.3. Other Logistics
  • 6.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 6.5.1. Phase I
    • 6.5.2. Phase II
    • 6.5.3. Phase III
    • 6.5.4. Phase IV
  • 6.6. Market Attractiveness Analysis

7. Europe Clinical Trial Kits Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Service Type
    • 7.2.3. By Phase
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 7.4.1. Kitting Solutions
      • 7.4.1.1. Drugs Kits
      • 7.4.1.2. Sample Collection Kits
    • 7.4.2. Logistics
      • 7.4.2.1. Transportation
      • 7.4.2.2. Warehousing & Storage
      • 7.4.2.3. Other Logistics
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 7.5.1. Phase I
    • 7.5.2. Phase II
    • 7.5.3. Phase III
    • 7.5.4. Phase IV
  • 7.6. Market Attractiveness Analysis

8. East Asia Clinical Trial Kits Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Service Type
    • 8.2.3. By Phase
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 8.4.1. Kitting Solutions
      • 8.4.1.1. Drugs Kits
      • 8.4.1.2. Sample Collection Kits
    • 8.4.2. Logistics
      • 8.4.2.1. Transportation
      • 8.4.2.2. Warehousing & Storage
      • 8.4.2.3. Other Logistics
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 8.5.1. Phase I
    • 8.5.2. Phase II
    • 8.5.3. Phase III
    • 8.5.4. Phase IV
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Clinical Trial Kits Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Service Type
    • 9.2.3. By Phase
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 9.4.1. Kitting Solutions
      • 9.4.1.1. Drugs Kits
      • 9.4.1.2. Sample Collection Kits
    • 9.4.2. Logistics
      • 9.4.2.1. Transportation
      • 9.4.2.2. Warehousing & Storage
      • 9.4.2.3. Other Logistics
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 9.5.1. Phase I
    • 9.5.2. Phase II
    • 9.5.3. Phase III
    • 9.5.4. Phase IV
  • 9.6. Market Attractiveness Analysis

10. Latin America Clinical Trial Kits Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Service Type
    • 10.2.3. By Phase
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 10.4.1. Kitting Solutions
      • 10.4.1.1. Drugs Kits
      • 10.4.1.2. Sample Collection Kits
    • 10.4.2. Logistics
      • 10.4.2.1. Transportation
      • 10.4.2.2. Warehousing & Storage
      • 10.4.2.3. Other Logistics
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 10.5.1. Phase I
    • 10.5.2. Phase II
    • 10.5.3. Phase III
    • 10.5.4. Phase IV
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Clinical Trial Kits Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Service Type
    • 11.2.3. By Phase
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
    • 11.4.1. Kitting Solutions
      • 11.4.1.1. Drugs Kits
      • 11.4.1.2. Sample Collection Kits
    • 11.4.2. Logistics
      • 11.4.2.1. Transportation
      • 11.4.2.2. Warehousing & Storage
      • 11.4.2.3. Other Logistics
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
    • 11.5.1. Phase I
    • 11.5.2. Phase II
    • 11.5.3. Phase III
    • 11.5.4. Phase IV
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Azenta Life Sciences
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Service Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Q2 Solutions
    • 12.3.3. Patheon
    • 12.3.4. LabCorp drug development
    • 12.3.5. Charles River Laboratories
    • 12.3.6. LabConnect
    • 12.3.7. Almac group
    • 12.3.8. Precision medicine group
    • 12.3.9. Cerba research
    • 12.3.10. Alpha Laboratories Ltd
    • 12.3.11. Marken SAS
    • 12.3.12. Clinigen

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations